US will roll out 15 million COVID-19 shots to children by next week | Inquirer
 
 
 
 
 
 

US will roll out 15 million COVID-19 shots to children by next week

08:30 AM November 02, 2021

The United States is rolling out Pfizer/BioNTech COVID-19 vaccines for children aged 5 to 11 this week, but most of the 15 million shots being shipped initially are unlikely to be available before next week, the White House said on Monday.

Millions of doses specifically formulated for children of that age group will start arriving at distribution centers over the next few days, White House coronavirus response coordinator Jeff Zients said, and the federal government has purchased enough supply for all eligible 28 million children.

“We are ready to execute, pending CDC’s decision. And starting the week of November 8th, our vaccination program for kids ages 5 through 11 will be running at full strength,” Zients told reporters at a briefing.

The U.S. Food and Drug Administration on Friday authorized the Pfizer Inc and BioNTech SE coronavirus vaccine for children aged 5 to 11 years, making it the first COVID-19 shot for young children in the United States.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

US will rollout 15 million COVID-19 shots to children by next week

A syringe is filled with a dose of Pfizer’s COVID-19 vaccine at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, U.S., February 23, 2021. REUTERS/Brendan McDermid

The U.S. Centers for Disease Control and Prevention still needs to advise on how the shot should be administered, which will be decided after a group of outside advisers discuss the plan on Tuesday.

Following the CDC’s decision, parents will be able to visit vaccines.gov and filter locations offering the vaccine for the children, Zients said.

“The whole plan is based on Pfizer vaccines,” he said.

ADVERTISEMENT

Moderna Inc said on Sunday it would delay filing its request for an emergency use authorization for a half-strength 50-microgram dose of the vaccine for children ages 6 to 11.

Shares in Moderna fell 2.3%, or $8.04, to $337.17 on Monday while Pfizer shares were off 10 cents at $43.64.

At the end of last week, the seven-day average number of coronavirus cases dropped 3% to around 69,000 daily cases, the average hospitalization rate fell 10% to around 5,100 cases, and the daily deaths average fell 10% to around 1,100, CDC Director Dr. Rochelle Walensky said at the same briefing.

U.S. Chief Medical Advisor Dr. Anthony Fauci said it was “very likely” everyone would be able to get a vaccine booster shot “within a reasonable amount of time.”

Currently the CDC recommendations for boosters cover specific categories of people.

(Reporting by Ahmed Aboulenein and Alexandra Alper; Additional reporting by Susan Heavey in Washington and Michael Erman in New Jersey; Editing by Alison Williams, Mark Porter and Marguerita Choy)

Want stories like this delivered straight to your inbox? Stay informed. Stay ahead. Subscribe to InqMORNING

Don't miss out on the latest news and information.
TAGS:
For feedback, complaints, or inquiries, contact us.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Stay informed. Stay ahead. Subscribe to InqMORNING

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.




This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.